Tobi Podhaler (tobramycin)

pCPA File Number: 20753

Negotiation Status:

Concluded with an LOI

Indication(s):

Pseuodomonas aeruginosa infections in cystic fibrosis

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2015-07-28

Negotiation Process Concluded:

2016-04-19